Avalon Trust’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.1K Hold
596
﹤0.01% 304
2026
Q1
$31.1K Hold
596
﹤0.01% 332
2025
Q4
$35.1K Sell
596
-8
-1% -$486 ﹤0.01% 311
2025
Q3
$33.6K Buy
604
+8
+1% +$429 ﹤0.01% 358
2025
Q2
$30.7K Hold
596
﹤0.01% 297
2025
Q1
$34.9K Hold
596
﹤0.01% 292
2024
Q4
$42.9K Hold
596
﹤0.01% 236
2024
Q3
$47.6K Hold
596
﹤0.01% 219
2024
Q2
$42.7K Hold
596
﹤0.01% 222
2024
Q1
$42K Hold
596
﹤0.01% 233
2023
Q4
$46K Hold
596
﹤0.01% 219
2023
Q3
$40.6K Hold
596
﹤0.01% 204
2023
Q2
$48.7K Hold
596
﹤0.01% 207
2023
Q1
$44.2K Buy
+596
New +$45.9K ﹤0.01% 208

Other funds holding TECH

Avalon Trust's TECH Position: Q2 2026 in Review

Avalon Trust held its Bio-Techne (TECH) position steady in Q2 2026 at 596 shares worth $42.1K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Avalon Trust first reported a position in TECH in Q1 2023 and has held it in 14 quarters since. The position peaked at $48.7K in Q2 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Avalon Trust held 596 shares of Bio-Techne worth $42.1K as of Q2 2026.
  • Avalon Trust left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #304 holding.
  • Avalon Trust first reported a position in Bio-Techne in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's Bio-Techne position peaked at $48.7K in Q2 2023.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.